These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17060668)

  • 1. Treatment with (R)-albuterol has no advantage over racemic albuterol.
    Barnes PJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):969-72; discussion 972-4. PubMed ID: 17060668
    [No Abstract]   [Full Text] [Related]  

  • 2. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
    Ameredes BT; Calhoun WJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):965-9; discussion 972-4. PubMed ID: 17060667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salamol--was it worth it?
    Beckert L; Edwards A
    N Z Med J; 2007 Dec; 120(1267):U2875. PubMed ID: 18157201
    [No Abstract]   [Full Text] [Related]  

  • 4. Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?
    Asmus MJ; Hendeles L
    Pharmacotherapy; 2000 Feb; 20(2):123-9. PubMed ID: 10678290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levalbuterol and racemic albuterol: are there therapeutic differences?
    Ahrens R; Weinberger M
    J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
    [No Abstract]   [Full Text] [Related]  

  • 6. Asthma pathophysiology and evidence-based treatment of severe exacerbations.
    Schreck DM
    Am J Health Syst Pharm; 2006 May; 63(10 Suppl 3):S5-13. PubMed ID: 16679429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levalbuterol versus albuterol.
    Ameredes BT; Calhoun WJ
    Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bronchodilators in the control of asthma.
    Rees PJ
    Natl Med J India; 1996; 9(4):153-4. PubMed ID: 8772328
    [No Abstract]   [Full Text] [Related]  

  • 9. A combination of fluticasone and salmeterol for asthma.
    Med Lett Drugs Ther; 2001 Apr; 43(1102):31-3. PubMed ID: 11309534
    [No Abstract]   [Full Text] [Related]  

  • 10. Salmeterol: a long-acting beta 2-agonist for asthma.
    Nurse Pract; 1994 Jul; 19(7):9-10. PubMed ID: 7936460
    [No Abstract]   [Full Text] [Related]  

  • 11. Levalbuterol hydrochloride.
    Slattery D; Wong SW; Colin AA
    Pediatr Pulmonol; 2002 Feb; 33(2):151-7. PubMed ID: 11802253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of asthma with salmeterol--a new prolonged-action inhalatory beta 2 agonist].
    Dahl R; Pedersen B
    Ugeskr Laeger; 1991 Oct; 153(44):3098-100. PubMed ID: 1683037
    [No Abstract]   [Full Text] [Related]  

  • 15. The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.
    Langley PC
    Clin Ther; 1999 Jan; 21(1):236-53. PubMed ID: 10090438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol for the treatment of asthma.
    Weinberger M
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
    [No Abstract]   [Full Text] [Related]  

  • 17. When the whole is more than the sum of its parts.
    Lanier BQ
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):445-6. PubMed ID: 11770689
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of beta-agonists on dose-response curves.
    Salome C; Woolcock A
    Eur Respir J; 1997 Oct; 10(10):2434-5. PubMed ID: 9387979
    [No Abstract]   [Full Text] [Related]  

  • 19. Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.
    Asmus MJ; Hendeles L; Weinberger M; Ahrens RC; Bisgaard H; Lötvall J; O'Byrne PM; Cockcroft DW
    J Allergy Clin Immunol; 2002 Aug; 110(2):325; author reply 325-8. PubMed ID: 12170277
    [No Abstract]   [Full Text] [Related]  

  • 20. [Variety of pharmacological action of beta agonists].
    Takahashi S; Kokubu F; Adachi M
    Arerugi; 1992 May; 41(5):557-62. PubMed ID: 1355646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.